Intra-tympanic corticosteroid for the treatment of primary immune-mediated sensorineural hearing loss

Abstract EN

Introduction : Development of sensorineural hearing loss [SNHL] leads to severe handicap that affects patient’s job, home and life.

Therefore, otologists should diagnose potentially treatable disorders to improve and / or even stabilize hearing.

Aim of work: Evaluation of intra-tympanic corticosteroids for the treatment of different types of SNHL.

Subjects and methods : Intra-tympanic injection of steroid under local anesthesia of 51 patients suffering from immune-mediated SNHL.

Audiological evaluation was done pre & post-injection.

Results : Hearing improvement of 23.41 dB by pure tone audiometry occurred in 43.2 % of patients .

Speech discrimination scores had improved by 30.1% in 78.4 % of patients.

Conclusion : Intra-tympanic steroid injection is a safe and promising tool for the treatment of immune-mediated SNHL